Glottis Ltd is a multimodal logistics provider that manages the international movement of goods via sea, air, and road, specializing in freight forwarding for the renewable energy and automotive sectors.
The company lacks a durable moat, as evidenced by a sharp decline in net margins to 3.7% and negative cash conversion. While they have a niche in solar logistics, the business is largely a price-taker in a commoditized freight market where profitability is dictated by global container rates rather than proprietary pricing power.
Management is currently transitioning from an asset-light model to an asset-heavy one by using IPO proceeds to purchase trailers and containers. While intended to capture more margin, this significantly increases fixed costs and depreciation in a cyclical downturn, which has yet to prove value-accretive given the recent EPS collapse.
The company's pivot from an asset-light model to an asset-heavy one proved disastrous as they bought equipment at the peak of the cycle. When global freight rates normalized, the massive increase in fixed costs and depreciation crushed the already thin 3.7% net margins. The aggressive 70% expansion of trade receivables, used to prop up revenue growth, eventually led to significant bad debt write-offs, while the negative cash conversion cycle starved the business of liquidity during a renewable energy sector downturn.
RichFakir rates Glottis Ltd's business quality as mediocre — 55/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Glottis Ltd is trading about 18% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Glottis Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Glottis Ltd's fair value is about ₹45 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →